Vanguard Global Advisers’s Greenwich LifeSciences GLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$42.4K Sell
2,348
-9,523
-80% -$159K ﹤0.01% 3118
2026
Q2
$278K Buy
11,871
+1,536
+15% +$37.4K ﹤0.01% 2365
2026
Q1
$248K Buy
+10,335
New +$270K ﹤0.01% 2333

Other funds holding GLSI

Vanguard Global Advisers's GLSI Position: Q3 2026 in Review

Vanguard Global Advisers reduced its Greenwich LifeSciences (GLSI) stake by 80% in Q3 2026, selling an estimated $159K and leaving 2,348 shares worth $42.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3118.

Vanguard Global Advisers first reported a position in GLSI in Q1 2026 and has held it in 3 quarters since. The position peaked at $278K in Q2 2026. 53 funds tracked by Wall St. Rank hold GLSI as of Q3 2026.

  • Vanguard Global Advisers held 2,348 shares of Greenwich LifeSciences worth $42.4K as of Q3 2026.
  • Vanguard Global Advisers sold 9,523 Greenwich LifeSciences shares in Q3 2026, an estimated $159K.
  • Greenwich LifeSciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3118 holding.
  • Vanguard Global Advisers first reported a position in Greenwich LifeSciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Greenwich LifeSciences position peaked at $278K in Q2 2026.
  • 53 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.